Gregory Heberlein
About Gregory Heberlein
Gregory Heberlein is an Associate Director of Process Development with extensive experience in the biopharmaceutical and biotechnology sectors. He has held various roles in companies such as Bayer, Kite Pharma, and WuXi Advanced Therapies, demonstrating a strong commitment to process development and quality control.
Work at Kite Pharma
Gregory Heberlein serves as the Associate Director of Process Development at Kite Pharma. He has held this position since 2020, contributing to the company's initiatives in the biopharmaceutical sector. His role involves overseeing and enhancing process development strategies, focusing on cell therapy solutions. Kite Pharma is recognized for its innovative approaches in cancer treatment, and Heberlein's expertise supports the company's mission in advancing therapeutic options.
Current Role at Bayer
Heberlein is currently the Director of the Cell Therapy Platform Process at Bayer, a position he has held since 2022. In this role, he is responsible for leading process development efforts within the cell therapy domain. His work in Berkeley, California, emphasizes the integration of scientific innovation with practical applications in biotechnology, aligning with Bayer's commitment to advancing healthcare solutions.
Previous Experience in Process Development
Before joining Kite Pharma, Heberlein worked at the Altius Institute for Biomedical Sciences as the Head of Process Development from 2019 to 2020. His prior roles also include significant positions at WuXi Advanced Therapies, where he served as Senior Scientist and Associate Principal Scientist in Process Development. These experiences have equipped him with a robust skill set in process optimization and development within the biotechnology field.
Educational Background
Gregory Heberlein earned a Bachelor of Science (B.S.) in Biology from Slippery Rock University of Pennsylvania, where he studied from 2002 to 2006. He furthered his education by obtaining a Master of Science (M.S.) in Biological Sciences from Clarion University of Pennsylvania between 2006 and 2008. His academic background provides a strong foundation for his career in the biopharmaceutical industry.
Career in Quality Control and Analysis
Heberlein has a diverse background in quality control and analysis, having worked as a Quality Control Analyst II at both SAIC and ABL, Inc. His experience in these roles, spanning from 2009 to 2014, involved ensuring compliance with industry standards and contributing to the quality assurance processes in biopharmaceutical development. This experience complements his process development expertise.